CI
CIB0.XETRA VanEck Bionic Engineering UCITS ETF A Acc EUR
- EUR
No recent price
- Total assets
- 4.75M
- Expense ratio
- 0.55%
- Dividend yield
- -
- 1-year return
- -2.60%
- Holdings
- 10
- Since
- 2022
Fund data as reported by the issuer, updated Nov 3, 2026. Total assets are in the fund's base currency.
What does CIB0.XETRA invest in?
Tracks Morningstar Gbl Health NR USD- Mostly US stocks (81.4%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (79.8%)
- Top 3 holdings: 32.6% of the fund
Asset allocation
- US stocks 81.4%
- Non-US stocks 20.1%
- Cash 0.1%
Top holdings
- Intuitive Surgical Inc 11.91%
- Stryker Corporation 10.39%
- Edwards Lifesciences Corp 10.27%
- Medtronic PLC 9.57%
- DexCom Inc 7.33%
VanEck Bionic Engineering UCITS ETF A Acc EUR performance
Sharpe ratio 0.15- This year
- -4.37%
- 1 year
- -2.60%
- 3 years
- +5.79%
- 5 years
- 0.00%
Volatility 17.4% over 1 year and 18.7% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
CIB0.XETRA price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
VanEck Bionic Engineering UCITS ETF A Acc EUR top holdings
68.7% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Intuitive Surgical Inc ISRG.US | Healthcare | United States | 11.91% |
| Stryker Corporation SYK.US | Healthcare | United States | 10.39% |
| Edwards Lifesciences Corp EW.US | Healthcare | United States | 10.27% |
| Medtronic PLC MDT.US | Healthcare | United States | 9.57% |
| DexCom Inc DXCM.US | Healthcare | United States | 7.33% |
| Sonova H Ag SOON.SW | Healthcare | Switzerland | 4.61% |
| Straumann Holding AG STMN.SW | Healthcare | Switzerland | 4.33% |
| Zimmer Biomet Holdings Inc ZBH.US | Healthcare | United States | 3.89% |
| Smith & Nephew SNATS Inc SNN.US | Healthcare | United States | 3.42% |
| Globus Medical GMED.US | Healthcare | United States | 3.00% |
CIB0.XETRA sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
CIB0.XETRA regional exposure
- North America79.8%
- Europe Developed14.0%
- United Kingdom3.6%
- Australasia2.8%
- Asia Emerging0.1%
Share of the stocks in the fund.
Company size
Average market cap 22.3B- Big cap33.0%
- Medium cap39.9%
- Small cap13.0%
- Micro cap14.1%
VanEck Bionic Engineering UCITS ETF A Acc EUR fund profile
- Fund name
- VanEck Bionic Engineering UCITS ETF A Acc EUR
- Ticker
- CIB0.XETRA
- Exchange
- XETRA Stock Exchange
- Index tracked
- Morningstar Gbl Health NR USD
- Category
- Healthcare Equity
- Domicile
- Irland
- Inception date
- Dec 2, 2022
- Trading currency
- EUR
- Expense ratio
- 0.55%